Dr. Vågesjö is co-founder and CEO of Ilya Pharma, a growth stage company developing next generation immunotherapies based on cutting edge medical research in immunophysiology and applied microbiology. She has received numerous awards within Science and Innovation, among these, she was one of the winners of Innovators Under 35 Europe from MIT Technology Review 2019 and was featured on the Global PowerList 2021 by the Medicine Maker. Dr. Vågesjö holds a Ph.D. in Physiology from Uppsala University and a MBA from Heriot-Watt University, Edinburgh.